Researchers in the public health team at Wisconsin Alzheimer’s Institute are working to understand how to bring research advances and tools from memory clinics into the primary care environment.
Claire Bitner
Dr. Maria Mora Pinzon leads education program to train medical students in advancing dementia care for Latinos
Researchers in Madison are partnering with a Milwaukee-based Latino community center to create a new, culturally competent, elective course for medical students at the University of Wisconsin School of Medicine and Public Health as an elective.
Dr. Nathaniel Chin discusses UW–Madison role in Alzheimer’s blood tests on regional media outlets
Nathaniel Chin, MD, medical director of the WRAP study, appeared on numerous Wisconsin news outlets to discuss the recent Food and Drug Administration (FDA) approval of a blood test for Alzheimer’s disease. The accuracy of the blood test was validated using data samples from the Wisconsin Alzheimer’s Disease Research Center (ADRC) and the Wisconsin Registry for Alzheimer’s Prevention (WRAP).
UW–Madison research helps launch first FDA-cleared blood test for Alzheimer’s disease
In a crucial advancement for Alzheimer’s disease diagnosis, the U.S. Food and Drug Administration (FDA) granted clearance for an Alzheimer’s disease blood test on May 16, 2025. The test is an in vitro diagnostic (IVD) assay capable of detecting amyloid — a key protein involved in Alzheimer’s disease — in blood. Data samples used to evaluate the validity of the test are from research conducted at the University of Wisconsin–Madison.
Breaking the Silence marks 11-Year anniversary with empowering community event
On behalf of the Wisconsin Alzheimer’s Institute Regional Milwaukee Office, thank you to everyone who attended the 11th Annual Breaking the Silence event!
Supporting Alzheimer’s and dementia caregivers: resources from the Wisconsin Alzheimer’s Institute
Caring for a loved one with Alzheimer’s or other dementia is a challenging responsibility. The Wisconsin Alzheimer’s Institute is dedicated to providing essential support and resources to caregivers, helping them navigate this difficult journey with compassion and expertise.
Dr. Sterling Johnson discusses blood testing for Alzheimer’s disease on neurology podcast
In the latest episode of the podcast Expert Voices in Dementia, Sterling Johnson, PhD, shares news about detecting Alzheimer’s disease through blood testing and the important implications this research could have on Alzheimer’s disease treatment. Johnson’s lab is investigating p-tau217 as a blood-based biomarker for early detection of Alzheimer’s disease.
Dr. Karly Cody wins de Leon award
The selected paper, which utilizes Wisconsin ADRC and WRAP participant data, maps a timeline of amyloid and tau accumulation in the brain
Dr. Sterling Johnson addresses impact of potential cuts to NIH funding at news conference
On March 6, Sterling Johnson, PhD, participated in a news conference for the media to discuss the importance of federally funded Alzheimer’s disease research at UW–Madison and its impact on people throughout Wisconsin and nationwide.
Updates about federal funding and UW Alzheimer’s disease research
To stay informed about federal funding changes that impact UW Alzheimer’s disease research programs, read the UW–Madison Office of Federal Relations updates page.